Clinical studies that involve the elderly must incorporate some unique statistical design and analysis considerations. Analysis of data from these studies as well as the collection of data require special efforts to assure that variations have been recognized and taken into account. Potential study designs and data presentations are discussed.
TempleR: FDA Discussion Paper on Testing of Drugs in the Elderly. Department of Health and Human Services, Public Health Service, Food and Drug Administration, September 1983.
